TY - JOUR AU - Hamdy, F. C. AU - Donovan, J. L. AU - Lane, J. A. AU - Mason, M. AU - Metcalfe, C. AU - Holding, P. PY - 2016 DA - 2016// TI - 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1606220 DO - 10.1056/NEJMoa1606220 ID - Hamdy2016 ER - TY - JOUR AU - Narang, A. K. AU - Gergis, C. AU - Robertson, S. P. AU - He, P. AU - Ram, A. N. AU - McNutt, T. R. PY - 2016 DA - 2016// TI - Very high-risk localized prostate cancer: outcomes following definitive radiation JO - Int J Radiat Oncol Biol Phys VL - 94 UR - https://doi.org/10.1016/j.ijrobp.2015.10.056 DO - 10.1016/j.ijrobp.2015.10.056 ID - Narang2016 ER - TY - JOUR AU - Isbarn, H. AU - Huland, H. AU - Graefen, M. PY - 2013 DA - 2013// TI - Results of radical prostatectomy in newly diagnosed prostate cancer: long-term survival rates in locally advanced and high-risk cancers JO - Dtsch Arztebl Int VL - 110 ID - Isbarn2013 ER - TY - JOUR AU - Valicenti, R. K. AU - Thompson, I. AU - Albertsen, P. AU - Davis, B. J. AU - Goldenberg, S. L. AU - Wolf, J. S. PY - 2013 DA - 2013// TI - Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American urological association guidelines JO - Int J Radiat Oncol Biol Phys VL - 86 UR - https://doi.org/10.1016/j.ijrobp.2013.05.029 DO - 10.1016/j.ijrobp.2013.05.029 ID - Valicenti2013 ER - TY - JOUR AU - Peeters, S. T. H. AU - Heemsbergen, W. D. AU - Koper, P. C. M. AU - Putten, W. L. J. AU - Slot, A. AU - Dielwart, M. F. H. PY - 2006 DA - 2006// TI - Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.05.2530 DO - 10.1200/JCO.2005.05.2530 ID - Peeters2006 ER - TY - JOUR AU - Dearnaley, D. P. AU - Sydes, M. R. AU - Graham, J. D. AU - Aird, E. G. AU - Bottomley, D. AU - Cowan, R. A. PY - 2007 DA - 2007// TI - Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial JO - Lancet Oncol VL - 8 UR - https://doi.org/10.1016/S1470-2045(07)70143-2 DO - 10.1016/S1470-2045(07)70143-2 ID - Dearnaley2007 ER - TY - JOUR AU - King, C. R. PY - 2016 DA - 2016// TI - The dose-response of salvage radiotherapy following radical prostatectomy: a systematic review and meta-analysis JO - Radiother Oncol VL - 121 UR - https://doi.org/10.1016/j.radonc.2016.10.026 DO - 10.1016/j.radonc.2016.10.026 ID - King2016 ER - TY - JOUR AU - Ohri, N. AU - Dicker, A. P. AU - Trabulsi, E. J. AU - Showalter, T. N. PY - 2012 DA - 2012// TI - Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2011.08.013 DO - 10.1016/j.ejca.2011.08.013 ID - Ohri2012 ER - TY - JOUR AU - Ghadjar, P. AU - Hayoz, S. AU - Bernhard, J. AU - Zwahlen, D. R. AU - Hölscher, T. AU - Gut, P. PY - 2015 DA - 2015// TI - Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10 JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.63.3529 DO - 10.1200/JCO.2015.63.3529 ID - Ghadjar2015 ER - TY - JOUR AU - Stephenson, A. J. AU - Scardino, P. T. AU - Kattan, M. W. AU - Pisansky, T. M. AU - Slawin, K. M. AU - Klein, E. A. PY - 2007 DA - 2007// TI - Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.08.9607 DO - 10.1200/JCO.2006.08.9607 ID - Stephenson2007 ER - TY - JOUR AU - Ghosh, A. AU - Heston, W. D. W. PY - 2004 DA - 2004// TI - Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer JO - J Cell Biochem VL - 91 UR - https://doi.org/10.1002/jcb.10661 DO - 10.1002/jcb.10661 ID - Ghosh2004 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Avtzi, E. AU - Giesel, F. L. AU - Holland-Letz, T. AU - Linhart, H. G. AU - Eder, M. PY - 2015 DA - 2015// TI - The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-014-2949-6 DO - 10.1007/s00259-014-2949-6 ID - Afshar-Oromieh2015 ER - TY - JOUR AU - Eiber, M. AU - Maurer, T. AU - Souvatzoglou, M. AU - Beer, A. J. AU - Ruffani, A. AU - Haller, B. PY - 2015 DA - 2015// TI - Evaluation of hybrid 68Ga-PSMA Ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.115.154153 DO - 10.2967/jnumed.115.154153 ID - Eiber2015 ER - TY - JOUR AU - Perera, M. AU - Papa, N. AU - Christidis, D. AU - Wetherell, D. AU - Hofman, M. S. AU - Murphy, D. G. PY - 2016 DA - 2016// TI - Sensitivity, specificity, and predictors of positive (68)Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2016.06.021 DO - 10.1016/j.eururo.2016.06.021 ID - Perera2016 ER - TY - JOUR AU - Maurer, T. AU - Gschwend, J. E. AU - Rauscher, I. AU - Souvatzoglou, M. AU - Haller, B. AU - Weirich, G. PY - 2016 DA - 2016// TI - Diagnostic efficacy of (68)gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer JO - J Urol VL - 195 UR - https://doi.org/10.1016/j.juro.2015.12.025 DO - 10.1016/j.juro.2015.12.025 ID - Maurer2016 ER - TY - JOUR AU - Hövels, A. M. PY - 2008 DA - 2008// TI - Heesakkers R a. M, Adang EM, Jager GJ, strum S, Hoogeveen YL, et al. the diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis JO - Clin Radiol VL - 63 UR - https://doi.org/10.1016/j.crad.2007.05.022 DO - 10.1016/j.crad.2007.05.022 ID - Hövels2008 ER - TY - JOUR AU - Dewes, S. AU - Schiller, K. AU - Sauter, K. AU - Eiber, M. AU - Maurer, T. AU - Schwaiger, M. PY - 2016 DA - 2016// TI - Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study JO - Radiat Oncol VL - 11 UR - https://doi.org/10.1186/s13014-016-0646-2 DO - 10.1186/s13014-016-0646-2 ID - Dewes2016 ER - TY - JOUR AU - Sterzing, F. AU - Kratochwil, C. AU - Fiedler, H. AU - Katayama, S. AU - Habl, G. AU - Kopka, K. PY - 2016 DA - 2016// TI - (68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients JO - Eur J Nucl Med Mol Imaging VL - 43 UR - https://doi.org/10.1007/s00259-015-3188-1 DO - 10.1007/s00259-015-3188-1 ID - Sterzing2016 ER - TY - JOUR AU - Bluemel, C. AU - Linke, F. AU - Herrmann, K. AU - Simunovic, I. AU - Eiber, M. AU - Kestler, C. PY - 2016 DA - 2016// TI - Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy JO - EJNMMI Res VL - 6 UR - https://doi.org/10.1186/s13550-016-0233-4 DO - 10.1186/s13550-016-0233-4 ID - Bluemel2016 ER - TY - JOUR AU - Shakespeare, T. P. PY - 2015 DA - 2015// TI - Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0548-8 DO - 10.1186/s13014-015-0548-8 ID - Shakespeare2015 ER - TY - JOUR AU - Leeuwen, P. J. AU - Stricker, P. AU - Hruby, G. AU - Kneebone, A. AU - Ting, F. AU - Thompson, B. PY - 2016 DA - 2016// TI - (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment JO - BJU Int VL - 117 UR - https://doi.org/10.1111/bju.13397 DO - 10.1111/bju.13397 ID - Leeuwen2016 ER - TY - JOUR AU - Murphy, D. G. AU - Hofman, M. AU - Lawrentschuk, N. AU - Maurer, T. PY - 2017 DA - 2017// TI - Bringing clarity or confusion? The role of prostate-specific membrane antigen positron-emission/computed tomography for primary staging in prostate cancer JO - BJU Int VL - 119 UR - https://doi.org/10.1111/bju.13600 DO - 10.1111/bju.13600 ID - Murphy2017 ER - TY - STD TI - Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms [Internet]. Available from: http://www.awmf.org/leitlinien/detail/ll/043-022OL.html. Accessed 19 Aug 2017. UR - http://www.awmf.org/leitlinien/detail/ll/043-022OL.html ID - ref23 ER - TY - STD TI - NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Prostate Cancer Version 2.2017 — February 21, 2017 [Internet]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed 19 Aug 2017. UR - https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf ID - ref24 ER - TY - JOUR AU - Shore, N. D. AU - Abrahamsson, P. -. A. AU - Anderson, J. AU - Crawford, E. D. AU - Lange, P. PY - 2013 DA - 2013// TI - New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists JO - Prostate Cancer Prostatic Dis VL - 16 UR - https://doi.org/10.1038/pcan.2012.25 DO - 10.1038/pcan.2012.25 ID - Shore2013 ER - TY - JOUR AU - Kunath, F. AU - Borgmann, H. AU - Blümle, A. AU - Keck, B. AU - Wullich, B. AU - Schmucker, C. PY - 2015 DA - 2015// TI - Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer a systematic review with meta-analysis JO - BMJ Open VL - 5 UR - https://doi.org/10.1136/bmjopen-2015-008217 DO - 10.1136/bmjopen-2015-008217 ID - Kunath2015 ER - TY - JOUR AU - Song, C. AU - Kim, Y. S. AU - Hong, J. H. AU - Kim, C. -. S. AU - Ahn, H. PY - 2010 DA - 2010// TI - Treatment failure and clinical progression after salvage therapy in men with biochemical recurrence after radical prostatectomy: radiotherapy vs androgen deprivation JO - BJU Int VL - 106 UR - https://doi.org/10.1111/j.1464-410X.2009.09136.x DO - 10.1111/j.1464-410X.2009.09136.x ID - Song2010 ER - TY - JOUR AU - Trock, B. J. AU - Han, M. AU - Freedland, S. J. AU - Humphreys, E. B. AU - DeWeese, T. L. AU - Partin, A. W. PY - 2008 DA - 2008// TI - Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JO - JAMA VL - 299 UR - https://doi.org/10.1001/jama.299.23.2760 DO - 10.1001/jama.299.23.2760 ID - Trock2008 ER - TY - JOUR AU - Loeb, S. AU - Roehl, K. A. AU - Viprakasit, D. P. AU - Catalona, W. J. PY - 2008 DA - 2008// TI - Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy JO - Eur Urol VL - 54 UR - https://doi.org/10.1016/j.eururo.2008.03.066 DO - 10.1016/j.eururo.2008.03.066 ID - Loeb2008 ER - TY - JOUR AU - Jereczek-Fossa, B. A. AU - Orecchia, R. PY - 2007 DA - 2007// TI - Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer JO - Radiother Oncol VL - 84 UR - https://doi.org/10.1016/j.radonc.2007.04.013 DO - 10.1016/j.radonc.2007.04.013 ID - Jereczek-Fossa2007 ER - TY - JOUR AU - Tendulkar, R. D. AU - Agrawal, S. AU - Gao, T. AU - Efstathiou, J. A. AU - Pisansky, T. M. AU - Michalski, J. M. PY - 2016 DA - 2016// TI - Contemporary update of a multi-institutional predictive Nomogram for salvage radiotherapy after radical prostatectomy JO - J Clin Oncol. VL - 30 UR - https://doi.org/10.1200/JCO.2016.67.9647 DO - 10.1200/JCO.2016.67.9647 ID - Tendulkar2016 ER - TY - STD TI - Qiu S, Yang L, Deng L, Liu L, Han P, Wei Q. Efficacy and safety of prostate-targeted local therapy in patients with newly diagnosed oligometastatic prostate cancer: a systematic review and meta-analysis. Lancet, Suppl 1. 2016;388:S84. ID - ref32 ER - TY - JOUR AU - Broughman, J. R. AU - Chen, R. C. PY - 2017 DA - 2017// TI - Management of Node-Positive and Oligometastatic Prostate Cancer JO - Semin Radiat Oncol VL - 27 UR - https://doi.org/10.1016/j.semradonc.2016.08.006 DO - 10.1016/j.semradonc.2016.08.006 ID - Broughman2017 ER -